RPCEC00000365已完成1 期
VSSP as immunopotentiator for the treatment of renal cell carcinoma: first approach to the clinic - VSSP-MDSC
Center of Molecular Immunology (CIM)0 个研究点目标入组 15 人开始时间: 2021年4月8日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- N/a: Single Arm Study. Masking: Open. Control Group: Uncontrolled. Assignment: Single Group. Purpose: Treatment
入排标准
- 年龄范围
- 18 years 至 one（—）
- 性别
- All
入选标准
- •1. Patients with histologically confirmed metastatic renal cell carcinoma.
- •2. Patients aged equal/over 18 years.
- •3. Patients who consent to participate in the study by signing the informed consent model.
- •4. Patients with performance status = 3 according to ECOG scale.
排除标准
- •1. Patients receiving other IND.
- •2. Patients with decompensated chronic diseases.
- •3. Patients with criteria to be included in any clinical trial.
- •4. Patients who are pregnant or breastfeeding
- •5. Patients who have received (3 months prior) or are receiving treatment with corticosteroids and / or immunomodulators.
- •6. Patients with congenital or acquired immune deficiency at the time of inclusion.
研究者
相似试验
尚未招募
不适用
Evaluation of the interference in the immunity caused by anesthetics Sevoflurane versus Propofol in intraoperative obese patients (obesita): study protocol for a randomized clinical trialRBR-77kfj5Rede D'Or Sao Luiz S.A.
招募中
Unknown
Induction of immune tolerance in patients with severe food allergy through combination of oral immunotherapy and fructooligosaccharideKCT0009478Samsung Medical Center168
已完成
2 期
A Study on the Immune Response and Safety of an RSV Vaccine When Given to Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant and Are at an Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease and Compared to Healthy Adults 50 Years of Age and AboveRespiratory Syncytial Virus InfectionsNCT05921903GlaxoSmithKline386
尚未招募
1 期
Study to Evaluate the Effect of an Ayurveda Compound in Recurrent Respiratory InfectionsCTRI/2020/03/024389ational Institute of Ayurveda Jaipur
已完成
3 期
A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone or Co-administered With an Adjuvanted Vaccine Against Influenza in Adults Aged 65 Years and AboveRespiratory Syncytial Virus InfectionsNCT05568797GlaxoSmithKline1,045